Yifan Pharmaceutical Hits Day High with Strong 5.26% Intraday Surge

Yifan Pharmaceutical Co., Ltd. has experienced a significant uptick in its stock performance, gaining 5.26% on March 12, 2026. The stock reached an intraday high of CNY 14.37, showcasing its strong activity in the market. This performance stands in contrast to the China Shanghai Composite, which saw a slight decline of 0.1% on the same day. Over the past week, Yifan Pharmaceutical has shown a robust increase of 7.58%, and its one-month performance reflects a notable rise of 16.58%. Year-to-date, the stock has advanced by 18.73%, outperforming the broader market index, which has only gained 4.04%. Despite these positive short-term trends, the company faces challenges in terms of long-term growth, with net sales declining at an annual rate of 1.21% over the last five years. However, Yifan has reported positive results for the last five consecutive quarters, with operating cash flow reaching its highest at CNY 616.42 million. The stock's current dividend yield stands at 0.83%, indicating a steady return for shareholders amidst fluctuating market conditions.